3Tenke P, Kovacs B, Bjerklund Johansen TE. European and Asian Guidelines on management and prevention of catheter-as sociated urinary tract infections[J].Int J Antimierob Agents 2008,31 Suppl1 :S68- S78.
4Stamm WE. Urinary tract infections[M]//Bennett JV,Brachman PS, editors. 4t h ed. philadelphia : Lippincott Raven, 1998 : 477-485.
2Nickel J C, Wright J B, Ruseska I, et al. Antibiotic resistance of Pseudomonas aeruginosa colonizing a urinary catheter in vitro [J]. Eur J Clin Microbiol, 1985,4:213
3Kobayashi H. Biofilm Diseases: Its clinical manifestation and therapeutic possibilities of Macrolides [J].Am J Med,1995,99(Suppl 6A):26S
4Ichimiya T, Yamasake T, Nasu M. In vitro effects of antimicrobial agents on Pseudomonas aeruginosa biofilm formation [J].J Antimicrob Chemother, 1994,34:331
5Nagino K, Kobayashi H. Influence of macrolides on mucoid alginate biosynthetic enzyme from Pseudomonas aeruginosa [J].Clin Microbiol Infect, 1997,3:432
6Mitsuya Y, Kawai S, Kobayashi H. Influence of macrolides on guanosine diphospho-D-mannose dehydrogenase activity in Pseudomonas biofilm [J].J Infect Chemother,2000,6:45
7Anwar H, Strap J, Alberta E, et al. Establishment of aging biofilms: possible mechanism of bacterial resistance to antimicrobial therapy [J]. Antimicrob Agents Chemother, 1992,36:1347
8NCCLS (National Committee for Clinical Laboratory Standards). Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically[S]. Fourth edition; approved standard(2001). NCCLS Villanova,Pa
9Domingue G, Ellis B, Dasgupta M, et al. Testing antimicrobial susceptibilities of adherent bacteria by a method that incorporates Guidelines of the National Committee for Clinical Laboratory Standards [J]. J Clin Microbiol, 1994,32:2564
10Zhang H P, Hu B J, Li H Y, et al. Difference of the effect of ceftazidime on the early and mature Pseudomonas aeruginosa biofilm bacteria [J]. Chin J Lab Med,2003,26: 349
